|
Volumn 13, Issue 1, 2008, Pages 5-7
|
Targeted Anticancer Therapies: Mouse Models Help Uncover the Mechanisms of Tumor Escape (DOI:10.1016/j.ccr.2007.12.019);Targeted Anticancer Therapies: Mouse Models Help Uncover the Mechanisms of Tumor Escape
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
BETA CATENIN;
DOXYCYCLINE;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERLOTINIB;
GEFITINIB;
IMATINIB;
PROTEIN KINASE B;
PROTEIN P53;
TRASTUZUMAB;
CANCER INHIBITION;
CANCER PATIENT;
CANCER THERAPY;
CLINICAL EFFECTIVENESS;
CLINICAL PRACTICE;
DRUG RESPONSE;
DRUG TARGETING;
EXPERIMENTAL MODEL;
GENE;
GENE ACTIVATION;
GENE EXPRESSION;
GENE TARGETING;
MOUSE;
NONHUMAN;
ONCOGENE;
POINT MUTATION;
PRIORITY JOURNAL;
RELAPSE;
REPRESSOR GENE;
RUNX3 GENE;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
SURVIVAL TIME;
TRANSGENIC MOUSE;
TREATMENT PLANNING;
TUMOR ESCAPE;
TUMOR GROWTH;
TUMOR MODEL;
TUMOR REGRESSION;
TUMOR SUPPRESSOR GENE;
WNT1 GENE;
|
EID: 37349004468
PISSN: 15356108
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ccr.2008.02.012 Document Type: Erratum |
Times cited : (8)
|
References (13)
|